Shift Bioscience identifies novel single-gene target for safer cellular rejuvenation therapeutics
Shift Bioscience (SHIFT), a biotechnology company, which exposes biology of cell rejuvenation to develop new treatments for age-operated diseases, today announced the publication of new research that identifies a novel, single-gene target for cellular rejuvenation. In many cell types, capable of reversing cellular aging, without inspiring the dangerous pluripotency routes seen in other approaches, SB000 […]